Phase 1 Affective Disorder Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder

SchizophreniaSchizo Affective DisorderBipolar Disorder I+2 more

BioXcel Therapeutics Inc140 enrolled5 locationsNCT05025605

Recruiting

Phase 1Phase 2

Acetazolamide for Treatment Resistant Schizophrenia

SchizophreniaSchizo Affective Disorder

Vishwajit Nimgaonkar, MD PhD60 enrolled2 locationsNCT04887792

Recruiting

Phase 1Phase 2

Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia

SchizophreniaSchizo Affective Disorder

Vishwajit Nimgaonkar, MD PhD160 enrolled1 locationNCT03794076